Have a personal or library account? Click to login
Brief communication (Original). Hyperandrogenemia is associated with thin endometrium in reproductive-aged Thai women with polycystic ovary syndrome Cover

Brief communication (Original). Hyperandrogenemia is associated with thin endometrium in reproductive-aged Thai women with polycystic ovary syndrome

Open Access
|Feb 2017

References

  1. 1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005; 352:1223-36.10.1056/NEJMra041536
  2. 2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19:41-7.10.1093/humrep/deh098
  3. 3. Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol. 2001; 98:325-31.
  4. 4. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006; 20:235-44.10.1016/j.beem.2006.03.005
  5. 5. Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, et al. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol. 2006; 127:218-21.10.1016/j.ejogrb.2006.01.023
  6. 6. Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med. 2008; 26:62-71.10.1055/s-2007-992926
  7. 7. Ozdemir S, Gorkemli H, Gezginc K, Ozdemir M, Kiyici A. Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2008; 103:44-9.10.1016/j.ijgo.2008.05.017
  8. 8. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002; 81:799-816.10.1034/j.1600-0412.2001.810902.x
  9. 9. Bennett GL, Andreotti RF, Lee SI, Dejesus Allison SO, Brown DL, Dubinsky T, et al. ACR appropriateness criteria on abnormal vaginal bleeding. J Am Coll Radiol. 2011; 8:460-8.10.1016/j.jacr.2011.03.011
  10. 10. Wongwananuruk T, Indhavivadhana S, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, et al. Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital. J Med Assoc Thai. 2010; 93: 399-405.
  11. 11. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140:815-30.10.1016/0002-9378(81)90746-8
  12. 12. Speroff L, Fritz MA. Amenorrhea. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams&Wikins; 2005.
  13. 13. World Health Organization. Laboratory diagnosis and monitoring of diabetes mellitus. WHO 2002. Geneva:1-26.
  14. 14. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998; 83:2694-8.10.1210/jc.83.8.2694
  15. 15. Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A. Assessment of insulin resistance in young women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2008; 102:137-40.10.1016/j.ijgo.2008.03.017
  16. 16. Sengos C, Andreakos C, Iatrakis G. Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2000; 27:35-8.
  17. 17. Maiorano E, Loverro G, Viale G, Giannini T, Napoli A, Perlino E. Insulin-like growth factor-I expression in normal and diseased endometrium. Int J Cancer. 1999; 80:188-93.10.1002/(SICI)1097-0215(19990118)80:2<;188::AID-IJC5>3.0.CO;2-E
  18. 18. Speroff L, Fritz MA. Hirsutism. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia: Lippincott Williams & Wikins; 2005.
  19. 19. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2008; 15:485-97.10.1677/ERC-07-0064
  20. 20. Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008; 630:148-65.10.1007/978-0-387-78818-0_10
  21. 21. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002; 11:1531-43.
  22. 22. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 2004; 108: 425-32.10.1002/ijc.11529
  23. 23. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006; 91:4237-45.10.1210/jc.2006-0178
DOI: https://doi.org/10.5372/1905-7415.0704.210 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 545 - 551
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Suchada Indhavivadhana, Manee Rattanachaiyanont, Thanyarat Wongwananuruk, Kitirat Techatraisak, Prasong Tanmahasamut, Chongdee Dangrat, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.